Abbvie (ABBV) Market Valuation Declined While Tradition Capital Management Cut Its Stake; Ipg Photonics Com (IPGP) Holder Dalton Greiner Hartman Maher & Co Has Lowered Holding

June 18, 2018 - By Winifred Garcia

AbbVie Inc. (NYSE:ABBV) Logo

Tradition Capital Management Llc decreased its stake in Abbvie Inc. (ABBV) by 34.48% based on its latest 2018Q1 regulatory filing with the SEC. Tradition Capital Management Llc sold 35,465 shares as the company’s stock declined 16.83% with the market. The institutional investor held 67,404 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $6.38M, down from 102,869 at the end of the previous reported quarter. Tradition Capital Management Llc who had been investing in Abbvie Inc. for a number of months, seems to be less bullish one the $150.76 billion market cap company. The stock increased 0.83% or $0.82 during the last trading session, reaching $99.57. About 20.81 million shares traded or 126.42% up from the average. AbbVie Inc. (NYSE:ABBV) has risen 52.41% since June 18, 2017 and is uptrending. It has outperformed by 39.84% the S&P500. Some Historical ABBV News: 06/04/2018 – INCYTE- SAFETY PROFILE OBSERVED IN ECHO-301/KEYNOTE-252 WAS CONSISTENT WITH THAT OBSERVED IN STUDIES OF EPACADOSTAT IN COMBINATION WITH KEYTRUDA; 07/03/2018 – EMA- EMA RECOMMENDS IMMEDIATE SUSPENSION AND RECALL OF MULTIPLE SCLEROSIS MEDICINE ZINBRYTA; 26/04/2018 – AbbVie 1Q EPS $1.74; 10/04/2018 – AbbVie Remains Confident in NDA and Continues to Work With FDA to Bring Elagolix to Patients; 01/05/2018 – ABBVIE SUBMITS MAA FOR PLAQUE PSORIASIS TREATMENT RISANKIZUMAB; 17/05/2018 – AbbVie Presenting at Conference Jun 2; 25/04/2018 – Protocols: AbbVie advances its two star pipeline therapies, filing BLA for risankizumab and posting promising data for upadacitinib $ABBV; 17/04/2018 – Dynavax Provides New Durability of Response Data for SD-101 in Combination with KEYTRUDA┬« (pembrolizumab) in Melanoma at the 2; 22/04/2018 – DJ AbbVie Inc, Inst Holders, 1Q 2018 (ABBV); 05/04/2018 – BIOGEN INC – UNDER TERMS OF AGREEMENT, BIOGEN AND SAMSUNG BIOEPIS WILL MAKE ROYALTY PAYMENTS TO ABBVIE

Dalton Greiner Hartman Maher & Co decreased its stake in Ipg Photonics Corp Com (IPGP) by 32.31% based on its latest 2018Q1 regulatory filing with the SEC. Dalton Greiner Hartman Maher & Co sold 35,392 shares as the company’s stock rose 0.74% while stock markets declined. The institutional investor held 74,142 shares of the semiconductors company at the end of 2018Q1, valued at $17.30M, down from 109,534 at the end of the previous reported quarter. Dalton Greiner Hartman Maher & Co who had been investing in Ipg Photonics Corp Com for a number of months, seems to be less bullish one the $12.81 billion market cap company. The stock decreased 1.00% or $2.41 during the last trading session, reaching $238.57. About 104 shares traded. IPG Photonics Corporation (NASDAQ:IPGP) has risen 81.13% since June 18, 2017 and is uptrending. It has outperformed by 68.56% the S&P500. Some Historical IPGP News: 16/05/2018 – IPG Photonics to Participate in Upcoming Investor Conferences; 12/04/2018 – Agency Spy: Initiative L.A. Wins Amazon Studios Media Business as IPG Consolidates the Larger Amazon Account; 08/05/2018 – IPG Photonics Non-Deal Roadshow Set By Benchmark for May. 15; 01/05/2018 – IPG Photonics 1Q Rev $359.9M; 01/05/2018 – IPG Photonics Sees 2Q EPS $2.05-EPS $2.35; 21/04/2018 – DJ IPG Photonics Corporation, Inst Holders, 1Q 2018 (IPGP); 13/04/2018 – $12 Billion Opportunity by 2023 in the Global Laser Diode Market – Key Players are Coherent, IPG Photonics, OSRAM Licht, TRUMPf, and Jenoptik – ResearchAndMarkets.com; 01/05/2018 – IPG Photonics 1Q EPS $1.93; 01/05/2018 – IPG PHOTONICS SEES 2Q EPS $2.05 TO $2.35, EST. $2.19; 01/05/2018 – IPG PHOTONICS 1Q EPS $1.93, EST. $1.81

Since January 8, 2018, it had 0 buys, and 14 sales for $23.85 million activity. On Thursday, May 10 the insider Ness Trevor sold $1.50M. On Thursday, February 1 Mammen Timothy PV sold $1.26M worth of IPG Photonics Corporation (NASDAQ:IPGP) or 5,000 shares. 3,500 shares were sold by HURLEY WILLIAM S, worth $895,755 on Wednesday, March 14. Shcherbakov Eugene A also sold $2.44M worth of IPG Photonics Corporation (NASDAQ:IPGP) shares. PEELER JOHN R had sold 2,266 shares worth $573,185 on Monday, March 12. On Friday, January 12 GAUTHIER HENRY E sold $1.29 million worth of IPG Photonics Corporation (NASDAQ:IPGP) or 5,000 shares.

Investors sentiment decreased to 0.84 in 2018 Q1. Its down 0.09, from 0.93 in 2017Q4. It is negative, as 36 investors sold IPGP shares while 173 reduced holdings. 66 funds opened positions while 109 raised stakes. 28.90 million shares or 0.95% more from 28.63 million shares in 2017Q4 were reported. The New Jersey-based Private Advisor Gru Ltd Com has invested 0.02% in IPG Photonics Corporation (NASDAQ:IPGP). 15,769 are held by Pub Employees Retirement Sys Of Ohio. The New York-based Garrison Bradford And Associate Inc has invested 7% in IPG Photonics Corporation (NASDAQ:IPGP). 55,838 were accumulated by Asset One Co. Cibc accumulated 1,438 shares. Nine Masts Cap has invested 0.03% in IPG Photonics Corporation (NASDAQ:IPGP). British Columbia Investment Mngmt Corp reported 36,259 shares. Bridgeway Capital Mgmt owns 0.09% invested in IPG Photonics Corporation (NASDAQ:IPGP) for 35,990 shares. Eqis Capital Mgmt Inc holds 0.02% in IPG Photonics Corporation (NASDAQ:IPGP) or 1,640 shares. Jackson Square Limited Liability reported 0.39% stake. 1,881 were reported by Alps Advsr. S&Co has invested 0.05% in IPG Photonics Corporation (NASDAQ:IPGP). Aureus Asset Mngmt Ltd Liability Co accumulated 4,350 shares or 0.15% of the stock. Moreover, Brown Cap Ltd Co has 0.01% invested in IPG Photonics Corporation (NASDAQ:IPGP). Fuller And Thaler Asset Management owns 17,477 shares.

Dalton Greiner Hartman Maher & Co, which manages about $1.89B and $1.48B US Long portfolio, upped its stake in Lhc Group Inc Com (NASDAQ:LHCG) by 66,552 shares to 371,410 shares, valued at $22.86M in 2018Q1, according to the filing. It also increased its holding in Portland Gen Elec Co Com New (NYSE:POR) by 44,064 shares in the quarter, for a total of 364,668 shares, and has risen its stake in Ttm Technologies Inc Com (NASDAQ:TTMI).

Analysts await IPG Photonics Corporation (NASDAQ:IPGP) to report earnings on August, 7. They expect $2.22 earnings per share, up 16.23% or $0.31 from last year’s $1.91 per share. IPGP’s profit will be $119.20M for 26.87 P/E if the $2.22 EPS becomes a reality. After $1.93 actual earnings per share reported by IPG Photonics Corporation for the previous quarter, Wall Street now forecasts 15.03% EPS growth.

More recent IPG Photonics Corporation (NASDAQ:IPGP) news were published by: Fool.com which released: “These 3 Stocks Doubled in 2017 — Are They Still Buys?” on June 04, 2018. Also Fool.com published the news titled: “Wall Street Announces Ratings for nLIGHT: What You Need to Know” on May 21, 2018. Nasdaq.com‘s news article titled: “New Research Coverage Highlights Universal Insurance Holdings, Harmony Gold Mining Company, Schweitzer …” with publication date: June 07, 2018 was also an interesting one.

Among 14 analysts covering IPG Photonics (NASDAQ:IPGP), 10 have Buy rating, 0 Sell and 4 Hold. Therefore 71% are positive. IPG Photonics had 39 analyst reports since September 15, 2015 according to SRatingsIntel. Needham maintained IPG Photonics Corporation (NASDAQ:IPGP) rating on Tuesday, October 13. Needham has “Buy” rating and $98 target. The company was maintained on Wednesday, October 28 by Benchmark. The rating was upgraded by Dougherty & Company to “Buy” on Wednesday, February 15. Northcoast maintained it with “Buy” rating and $290.0 target in Wednesday, January 31 report. The firm has “Buy” rating by Benchmark given on Monday, January 30. The stock has “Hold” rating by Canaccord Genuity on Tuesday, August 1. The rating was maintained by Benchmark on Wednesday, August 2 with “Buy”. Benchmark maintained it with “Buy” rating and $25500 target in Wednesday, May 2 report. The stock of IPG Photonics Corporation (NASDAQ:IPGP) has “Outperform” rating given on Friday, April 29 by Credit Agricole. The firm has “Hold” rating by Canaccord Genuity given on Tuesday, July 18.

Investors sentiment decreased to 0.7 in Q1 2018. Its down 0.10, from 0.8 in 2017Q4. It worsened, as 61 investors sold ABBV shares while 737 reduced holdings. 127 funds opened positions while 428 raised stakes. 1.06 billion shares or 0.67% less from 1.06 billion shares in 2017Q4 were reported. Duff Phelps Inv Management Com owns 17,160 shares. M&T National Bank reported 1.23M shares. Apriem has 1.55% invested in AbbVie Inc. (NYSE:ABBV). Gamble Jones Inv Counsel stated it has 162,374 shares. Focused Wealth Mgmt owns 1,417 shares. Sarissa Capital Mgmt Ltd Partnership invested in 1,000 shares or 0.02% of the stock. Hbk Sorce Advisory Limited Com reported 0.21% in AbbVie Inc. (NYSE:ABBV). Savings Bank Of The Ozarks invested in 1.36% or 36,216 shares. Torray Ltd Limited Liability Company holds 0.15% or 15,230 shares. Covington Advisors has 0.94% invested in AbbVie Inc. (NYSE:ABBV). Jfs Wealth Advsrs Ltd Company holds 0.03% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 1,168 shares. Central Bankshares And Co stated it has 7,897 shares or 0.19% of all its holdings. Allsquare Wealth Limited Liability Company invested 0.15% of its portfolio in AbbVie Inc. (NYSE:ABBV). Schwab Charles Management Inc stated it has 6.09M shares or 0.45% of all its holdings. Buckingham Capital holds 40,007 shares.

Among 24 analysts covering Abbvie Inc (NYSE:ABBV), 9 have Buy rating, 3 Sell and 12 Hold. Therefore 38% are positive. Abbvie Inc had 96 analyst reports since July 21, 2015 according to SRatingsIntel. UBS maintained it with “Buy” rating and $78 target in Friday, October 23 report. The stock of AbbVie Inc. (NYSE:ABBV) earned “Neutral” rating by Credit Suisse on Friday, April 27. As per Monday, March 26, the company rating was maintained by Bank of America. TheStreet upgraded the stock to “Buy” rating in Tuesday, August 11 report. The rating was maintained by BMO Capital Markets with “Underperform” on Wednesday, May 23. The company was maintained on Friday, January 26 by Cowen & Co. Credit Suisse maintained the stock with “Hold” rating in Wednesday, June 7 report. Jefferies maintained the stock with “Buy” rating in Friday, March 23 report. Morgan Stanley maintained it with “Equal-Weight” rating and $110 target in Monday, April 30 report. The stock of AbbVie Inc. (NYSE:ABBV) has “Hold” rating given on Thursday, March 22 by Leerink Swann.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on July, 27. They expect $1.97 EPS, up 38.73% or $0.55 from last year’s $1.42 per share. ABBV’s profit will be $2.98B for 12.64 P/E if the $1.97 EPS becomes a reality. After $1.87 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 5.35% EPS growth.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Benzinga.com which released: “Benzinga’s Bulls & Bears Of The Week: AbbVie, Lululemon, Netflix, Snap And More” on June 03, 2018, also Seekingalpha.com with their article: “Premarket analyst action – healthcare” published on June 01, 2018, Seekingalpha.com published: “More Thoughts On AbbVie’s Rova-T Implosion” on June 06, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Fool.com and their article: “Big Pharma Stock Investors Beware: Another $250 Billion Patent Cliff Is Coming” published on June 17, 2018 as well as Fool.com‘s news article titled: “Better Buy: AbbVie Inc. vs. GlaxoSmithKline plc” with publication date: June 15, 2018.

Tradition Capital Management Llc, which manages about $456.39 million and $349.59 million US Long portfolio, upped its stake in Walt Disney Company (NYSE:DIS) by 11,650 shares to 22,815 shares, valued at $2.29 million in 2018Q1, according to the filing. It also increased its holding in Medtronic Plc (NYSE:MDT) by 5,333 shares in the quarter, for a total of 66,688 shares, and has risen its stake in F.N.B. Corporation (NYSE:FNB).

IPG Photonics Corporation (NASDAQ:IPGP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: